Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages

Pathology Research and Practice

Volumn 209, Issue 8, 2013, Pages 516-520

  Podgornik, Helena ^a   Sok, Miha ^a   Kern, Izidor ^b   Marc, Janja ^c   Cerne, Darko ^c  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Gene expression; Lipoprotein lipase; Non small cell lung cancer; Tumor associated macrophages

Indexed keywords

CD14 ANTIGEN; CD163 ANTIGEN; FATTY ACID SYNTHASE; FOLATE RECEPTOR 2; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADULT; AGED; ARTICLE; CD163 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID SYNTHASE GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLATE RECEPTOR 2 GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; LUNG NON SMALL CELL CANCER; MACROPHAGE SCAVENGER RECEPTOR 1 GENE; MALE; STEROL REGULATORY ELEMENT BINDING TRANSCRIPTION FACTOR 1 GENE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

GENE EXPRESSION; LIPOPROTEIN LIPASE; NON-SMALL CELL LUNG CANCER; TUMOR ASSOCIATED MACROPHAGES;

AGED; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOPROTEIN LIPASE; LUNG NEOPLASMS; MACROPHAGES; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84881558068     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.06.004     Document Type: Article

References (25)

1. Bak S.P., Walters J.J., Takeya M., Conejo-Garcia J.R., Berwin B.L. Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression. Cancer Res. 2007, 67:4783-4789.
2. Carroll R., Severson D.L. Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H888-H894.
3. Cerne D., Melkic E., Trost Z., Sok M., Marc J. Lipoprotein lipase activity and gene expression in lung cancer and in adjacent noncancer lung tissue. Exp. Lung Res. 2007, 33:217-225.
4. Cerne D., Zitnik I.P., Sok M. Increased fatty acid synthase activity in non-small cell lung cancer tissue is a weaker predictor of shorter patient survival than increased lipoprotein lipase activity. Arch. Med. Res. 2010, 41:405-409.
5. Cerne D. Increased lipoprotein lipase activity in non-small lung cancer tissue predicts shorter patient survival. Arch. Med. Res. 2010, 41:65.
6. Crich S.G., Lanzardo S., Alberti D., Belfiore S., Ciampa A., Giovenzana G.B., Lovazzano C., Pagliarin R., Aime S. Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles. Neoplasia 2007, 9:1046-1056.
7. Cruz W.S., Kwon G., Marshall C.A., McDaniel M.L., Semenkovich C.F. Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells, a potential link between insulin resistance and beta-cell dysfunction. J. Biol. Chem. 2001, 276:12162-12168.
8. Dirks R.W., van de Rijke F.M., Fujishita S., van der Ploeg M., Raap A.K. Methodologies for specific intron and exon RNA localization in cultured cells by haptenized and fluorochromized probes. J. Cell Sci. 1993, 104:1187-1197.
9. Gann P.H., Hennekens C.H., Sacks F.M., Grodstein F., Giovannucci E.L., Stampfer M.J. Prospective study of plasma fatty acids and risk of prostate cancer. J. Natl. Cancer Inst. 1994, 86:281-286.
10. Gbaguidi F.G., Chinetti G., Milosavljevic D., Teissier E., Chapman J., Olivecrona G., Fruchart J.C., Griglio S., Fruchart-Najib J., Staels B. Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages. FEBS Lett. 2002, 512:85-90.
11. Kawamura K., Komohara Y., Takaishi K., Katabuchi H., Takeya M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol. Int. 2009, 59:300-305.
12. Mashima T., Seimiya H., Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer 2009, 100:1369-1372.
13. Mulligan H.D., Tisdale M.J. Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo. Br. J. Cancer 1991, 64:1035-1038.
14. Niho N., Takahashi M., Kitamura T., Shoji Y., Itoh M., Noda T., Sugimura T., Wakabayashi K. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res. 2003, 63:6090-6095.
15. Nomura K., Noguchi Y., Matsumoto A. Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate. Surg. Today 1996, 26:89-94.
16. Preiss-Landl K., Zimmermann R., Hammerle G., Zechner R. Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr. Opin. Lipidol. 2002, 13:471-481.
17. Pucci F., Venneri M.A., Biziato D., Nonis A., Moi D., Sica A., Di Serio C., Naldini L., De Palma M. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood resident monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 2009, 114:901-914.
18. Puig-Kröger A., Sierra-Filardi E., Domínguez-Soto A., Samaniego R., Corcuera M.T., Gómez-Aguado F., Ratnam M., Sánchez-Mateos P., Corbí A.L. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res. 2009, 69:9395-9403.
19. Sakayama K., Masuno H., Miyazaki T., Okumura H., Shibata T., Okuda H. Existence of lipoprotein lipase in human sarcomas and carcinomas. Jpn. J. Cancer Res. 1994, 85:515-521.
20. Sakayama K., Mashima N., Kidani T., Miyazaki T., Yamamoto H., Masuno H. Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line. Cancer Chemother. Pharmacol. 2008, 61:471-479.
21. Sobin L.H., Wittekind C. TNM Classification of Malignant Tumours 2002, John Wiley & Sons, New York. sixth ed.
22. Solinas G., Germano G., Mantovani A., Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 2009, 86:1065-1073.
23. Trost Z., Sok M., Marc J., Cerne D.D. Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival. Arch. Med. Res. 2009, 40:364-368.
24. Wu G., Brouckaert P., Olivecrona T. Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is involved. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E711-E717.
25. Ylä-Herttuala S., Lipton B.A., Rosenfeld M.E., Goldberg I.J., Steinberg D., Witztum J.L. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:10143-10147.